Login / Signup

Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer.

Jen-Pin ChuangHsiang-Lin TsaiPo-Jung ChenTsung-Kun ChangWei-Chih SuYung-Sung YehChing-Wen HuangJaw-Yuan Wang
Published in: Cells (2022)
Despite the implementation of global screening programs, colorectal cancer (CRC) remains the second leading cause of cancer-related deaths worldwide. More than 10% of patients with colon cancer are diagnosed as having locally advanced disease with a relatively poor five-year survival rate. Locally advanced colon cancer (LACC) presents surgical challenges to R0 resection. The advantages and disadvantages of preoperative radiotherapy for LACC remain undetermined. Although several reliable novel biomarkers have been proposed for the prediction and prognosis of CRC, few studies have focused solely on the treatment of LACC. This comprehensive review highlights the role of predictive biomarkers for treatment and postoperative oncological outcomes for patients with LACC. Moreover, this review discusses emerging needs and approaches for the discovery of biomarkers that can facilitate the development of new therapeutic targets and surveillance of patients with LACC.
Keyphrases